germany

The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with…

The findings were published in a report which provides vital insights into the world’s leading pharma economies across all…

The results see the country consolidate its status as an elite pharmaceutical market, finishing ahead of its European rivals in…

Fuhrmann has been associated with TÜV Rheinland Group for the past 18 years